Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Similar stories
6 outlets
See how this story developed, hour by hour
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
aljazeera.com
19.08.2026
A New Personalized Cancer Vaccine Could Keep Skin Cancer From Coming Back, Drugmakers Say
smithsonianmag.com
21.08.2026
Harry and Meghan to return to UK | Hopes for skin cancer vaccine
news.sky.com
20.08.2026
This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results
finance.yahoo.com
19.08.2026
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
19.08.2026
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
time.com
19.08.2026
Related stories
‘Work is good for you’: how UK scheme could help tackle youth mental health crisis
Drugstores say Medicare's $50 obesity drug program is catching on
5 Things About Dolly Parton You Didn’t Know: From Producing ‘Buffy the Vampire Slayer’ to the COVID Vaccine
5 Things About Dolly Parton You Didn’t Know: From Producing ‘Buffy the Vampire Slayer’ to the COVID Vaccine
Catholic bishops tell Florida there's no religious reason for vaccine exemptions
Recalls paint only part of the food safety picture